Literature DB >> 20425850

Association among lung function, exhaled nitric oxide, and the CAN questionnaire to assess asthma control in children.

O Sardón-Prado1, J Korta-Murua, J Valverde-Molina, J J Fernández-Paredes, J Mintegui, P Corcuera-Elosegui, J I Emparanza, E G Pérez-Yarza.   

Abstract

BACKGROUND: The aim of this study was to investigate the association among a validated symptom-based questionnaire for asthma control in children (CAN), forced expiratory volume in 1 sec (FEV(1)), and fractional exhaled nitric oxide (FE(NO)).
METHODS: Observational cross-sectional study was performed in a consecutive sample of asthmatic children aged between 7 and 14 years old from December 2007 to February 2008. FE(NO) was measured with a portable electrochemical analyzer and forced spirometry was performed according to American Thoracic Society/European Respiratory Society. The CAN questionnaire was completed by the parents (aged <9 years old) or by the children (> or = 9 years old). The strength of the association among FEV(1), FE(NO), and CAN questionnaire was studied using Spearman's rho, and the degree of agreement for asthma control among FEV(1), FE(NO), and CAN questionnaire, with classification of these variables according to values of normality, was studied using Pearson's chi(2) test and Cohen's kappa (KC).
RESULTS: We studied 268 children, mean age 9.7 +/- 2.1 years. Significant correlations were found between FE(NO) and CAN (r = 0.2), between FEV(1) and CAN (r = -0.3), and between FE(NO) and FEV(1) (r = -0.12). On classifying the variables according to values of normality, no agreement was found to establish the degree of asthma control between FE(NO) and CAN (KC = 0.18, chi(2) Pearson = 9.63); between FEV(1) and CAN (KC = 0.29, chi(2) = 38.5); or between FE(NO) and FEV(1) (KC = 0.07, chi(2) = 4.9).
CONCLUSIONS: The association among the three measurement instruments used to assess asthma control (FEV(1), FE(NO), and CAN) was weak. These are instruments that quantify variables that influence asthma in different ways, in this sense, none can be used instead of another in asthma management although they are complementary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425850     DOI: 10.1002/ppul.21144

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Comparing Asthma Control Questionnaire (ACQ) and National Asthma Education and Prevention Program (NAEPP) asthma control criteria.

Authors:  Hyekyun Rhee; Tanzy Love; Jennifer Mammen
Journal:  Ann Allergy Asthma Immunol       Date:  2018-09-11       Impact factor: 6.347

2.  Differences in spirometry values between U.S. children 6-11 years and adolescents 12-19 years with current asthma, 2007-2010.

Authors:  Brian K Kit; Alan E Simon; Timothy Tilert; Sande Okelo; Lara J Akinbami
Journal:  Pediatr Pulmonol       Date:  2015-07-07

Review 3.  An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma.

Authors:  Devika R Rao; Wanda Phipatanakul
Journal:  Expert Rev Clin Immunol       Date:  2016-02-19       Impact factor: 4.473

4.  Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children.

Authors:  Samuel H Wedes; Weijia Wu; Suzy A A Comhair; Karen M McDowell; Joseph A DiDonato; Serpil C Erzurum; Stanley L Hazen
Journal:  J Pediatr       Date:  2011-03-10       Impact factor: 4.406

Review 5.  [Research progress in relationship between fractional exhaled nitric oxide and asthma in children].

Authors:  Jing Zeng; Wei Liao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

Review 6.  Clinical utility of asthma biomarkers: from bench to bedside.

Authors:  Susanne Jh Vijverberg; Bart Hilvering; Jan Am Raaijmakers; Jan-Willem J Lammers; Anke-Hilse Maitland-van der Zee; Leo Koenderman
Journal:  Biologics       Date:  2013-08-29

7.  [Asthmatic exacerbations: specific features in children].

Authors:  A Carsin; N Pham-Thi
Journal:  Rev Mal Respir       Date:  2011-11-12       Impact factor: 0.622

8.  Alveolar nitric oxide and its role in pediatric asthma control assessment.

Authors:  Olaia Sardón; Paula Corcuera; Ane Aldasoro; Javier Korta; Javier Mintegui; José I Emparanza; Eduardo G Pérez-Yarza
Journal:  BMC Pulm Med       Date:  2014-08-04       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.